Q1 2017 13F Holders as of 3/31/2017
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
71.9M
-
Number of holders
-
35
-
Total 13F shares, excl. options
-
18.9M
-
Shares change
-
-2.84M
-
Total reported value, excl. options
-
$108M
-
Value change
-
-$16.5M
-
Number of buys
-
13
-
Number of sells
-
-20
-
Price
-
$5.73
Significant Holders of SINOVAC BIOTECH LTD. - Common Shares (SVA) as of Q1 2017
41 filings reported holding SVA - SINOVAC BIOTECH LTD. - Common Shares as of Q1 2017.
SINOVAC BIOTECH LTD. - Common Shares (SVA) has 35 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18.9M shares
of 71.9M outstanding shares and own 26.31% of the company stock.
Largest 10 shareholders include SAIF Advisors Ltd (10.8M shares), MORGAN STANLEY (2.72M shares), ORBIMED ADVISORS LLC (2.67M shares), RENAISSANCE TECHNOLOGIES LLC (1.68M shares), TWO SIGMA INVESTMENTS, LP (192K shares), Eqis Capital Management, Inc. (156K shares), GLG Partners LP (115K shares), Invesco Ltd. (99.1K shares), CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM (62K shares), and MILLENNIUM MANAGEMENT LLC (55.9K shares).
This table shows the top 35 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.